Tumor necrosis factor alpha inhibitors in Behçet's disease: indications, efficacy, and safety of two widely used agents.
Behçet's disease (BD) is characterized by relapsing mucocutaneous and major organ involvement. Although conventional immunosuppressants and CSs remain the mainstay of therapy, severe or refractory cases often require biologics. TNF-α inhibitors, particularly inflixima…